Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair M Thompson

Showing results (31-40 of 195) with videos related to

Pageof 20
Sort By:
Current Breast Cancer Reports|December 15, 2010
Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?Arnaud H Chauviere, Haralampos Hatzikirou, John S Lowengrub, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 23, 2019
Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?Sarah L Savaridas, Yee Ting Sim, Sarah J Vinnicombe, et al.
European Radiology|May 20, 2017
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancerShelley Henderson, Colin Purdie, Caroline Michie, et al.
International Journal of Cancer|November 12, 2009
High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancerPankaj G Roy, Norman Pratt, Colin A Purdie, et al.
Breast Cancer Research and Treatment|August 2, 2019
The time-varying effect of radiotherapy after breast-conserving surgery for DCISEileen Rakovitch, Rinku Sutradhar, Michael Hallett, et al.
Cancer Research|January 13, 2011
Physical oncology: a bench-to-bedside quantitative and predictive approachHermann B Frieboes, Mark A J Chaplain, Alastair M Thompson, et al.
Breast Cancer Research : BCR|November 10, 2010
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)Alastair M Thompson, Lee B Jordan, Philip Quinlan, et al.
NPJ Precision Oncology|September 9, 2022
Impact of TP53 mutations in Triple Negative Breast CancerZahi I Mitri, Nour Abuhadra, Shaun M Goodyear, et al.
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2012
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoestersTim A D Smith, M Virginia C L Appleyard, Sheila Sharp, et al.
Pageof 20

Showing results (31-40 of 195) with videos related to

Sort By:
Pageof 20
Current Breast Cancer Reports|December 15, 2010
Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?Arnaud H Chauviere, Haralampos Hatzikirou, John S Lowengrub, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 23, 2019
Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?Sarah L Savaridas, Yee Ting Sim, Sarah J Vinnicombe, et al.
European Radiology|May 20, 2017
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancerShelley Henderson, Colin Purdie, Caroline Michie, et al.
International Journal of Cancer|November 12, 2009
High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancerPankaj G Roy, Norman Pratt, Colin A Purdie, et al.
Breast Cancer Research and Treatment|August 2, 2019
The time-varying effect of radiotherapy after breast-conserving surgery for DCISEileen Rakovitch, Rinku Sutradhar, Michael Hallett, et al.
Cancer Research|January 13, 2011
Physical oncology: a bench-to-bedside quantitative and predictive approachHermann B Frieboes, Mark A J Chaplain, Alastair M Thompson, et al.
Breast Cancer Research : BCR|November 10, 2010
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)Alastair M Thompson, Lee B Jordan, Philip Quinlan, et al.
NPJ Precision Oncology|September 9, 2022
Impact of TP53 mutations in Triple Negative Breast CancerZahi I Mitri, Nour Abuhadra, Shaun M Goodyear, et al.
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2012
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoestersTim A D Smith, M Virginia C L Appleyard, Sheila Sharp, et al.
Pageof 20